Nasus Pharma Ltd Operating Cash Flow
Nasus Pharma Ltd (NSRX) reported Operating Cash Flow of -$4.92 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-03-25
| Period end | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|
| 2025-12-31 | -$4.92M 20-F · filed 2026-03-25 | |
| 2025-06-30 | -$433.00K 6-K · filed 2025-12-29 | |
| 2024-12-31 | -$665.00K 20-F · filed 2026-03-25 | |
| 2024-06-30 | -$180.00K 6-K · filed 2025-12-29 | |
| 2023-12-31 | -$1.03M 20-F · filed 2026-03-25 |